Article
Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo.
PLoS neglected tropical diseases - 1 Oct 2014
Pyana Pati Patient, Van Reet Nick, Mumba Ngoyi Dieudonné, Ngay Lukusa Ipos, Karhemere Bin Shamamba Stomy, Büscher Philippe
Abstract excerpt
BACKGROUND: Sleeping sickness caused by Trypanosoma brucei (T.b.) gambiense constitutes a serious health problem in sub-Sahara Africa. In some foci, alarmingly high relapse rates were observed in patients treated with melarsoprol, which used to be the first line treatment for patients in the neurological disease stage. Particularly problematic was the situation in Mbuji-Mayi, East Kasai Province in the Democratic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.